Glenmark's arm IGI Therapeutics signs a $700 million licensing deal with AbbVie for its cancer drug ISB 2001, with potential ...

Early-onset colorectal cancer rates are surging around the world, and Millennials are in the crosshairs. A new study has some startling stats.

A total of 2,92,996 were surveyed since March 8 there, during which they had to answer a questionnaire related to cancer symptoms, Abitkar said in a written reply in the House.

India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have ...

Brunch presenter Morgan McGlynn Carr has revealed she's been diagnosed with breast cancer. The Channel 4 star shared a snap ...

About seven-in-ten Americans say insurance companies have too much health policy influence, but partisans disagree on the CDC ...

The breast cancer risk assessment test that detected Olivia Munn's aggressive Luminal B cancer has now identified breast ...

AbbVie has placed a high price on that potential, coughing up $700 million for a phase 1 candidate and offering up to $1.225 ...

After Olivia Munn was diagnosed with breast cancer in 2023, she urged her mom and sister to take a risk assessment test.

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

While sites have not been finalized, the clinical trial will likely take place in Houston, the company's chief science ...

The last time it was announced that Mary Beckerle would be leaving the Huntsman Cancer Institute, there was uproar. But this ...